The U.S. Department of Health and Medical Research, the U.S. Food and Drug Administration (FDA), and U.S. President Donald Trump have approved the emergency treatment of other patients with blood plasma from patients recovering from corona.
Blood plasma corona patients were already being tested in the United States, and many health experts agreed that the method was useful on an emergency basis.
However, several US health experts believed that more research was needed on the treatment of blood plasma, but the FDA was under pressure to allow patients to be treated in this way.
In recent days, senior White House officials, and even Donald Trump himself, have accused the FDA of not approving Corona’s treatment of patients on political grounds.
Immediately after the FDA, Donald Trump also announced the approval. Photo: AP
According to the news agency Reuters, after Donald Trump’s accusations against the FDA for politicizing the treatment of corona disease, the health department approved the treatment of corona patients with blood plasma.
The FDA on August 23 approved the emergency treatment of other Corona patients with blood plasma from patients recovering from Corona.
That is, health professionals can treat any corona patient with blood plasma only if the patient’s condition is critical or he needs emergency treatment.
Following the FDA’s approval, US President Donald Trump also announced at a press conference that he would approve the emergency treatment of corona patients with blood plasma.
According to the Associated Press (AP), Donald Trump called the approval to treat corona patients with blood plasma an important development.
Top US health officials welcomed the government’s decision to allow blood plasma to be used to treat corona patients, but some officials called for more research into the matter.
In addition to the United States, other patients are being treated with blood plasma from Corona patients in several countries, and the method is being tested in Pakistan.
According to most health experts in many countries, blood plasma therapy has so far yielded significant results and is beneficial to patients with coronary heart disease.
Corona patients are currently being treated around the world in a variety of ways, including blood plasma, as no corona vaccine has yet been developed in the world.
More than 100 companies and companies from several countries, including the United States, Britain, China, Germany, France, Israel, India and Canada, are currently developing the corona vaccine, but no vaccine has yet emerged.
It is thought that the corona vaccine will take another three to four months to develop, but it is too early to say.